Patient preferences for the chemoprevention of colorectal cancer

Chin Hur; Broughton, Darcy E.; Chung Yin Kong; Ozanne, Elissa M.; Richards, Ethan B.; Truong, Thanh; Gazelle, G. Scott; Hur, Chin; Kong, Chung Yin
October 2009
Digestive Diseases & Sciences;Oct2009, Vol. 54 Issue 10, p2207
Academic Journal
journal article
Although evidence suggests that aspirin and celecoxib may reduce the risk of colorectal cancer (CRC), these drugs can also cause harmful side effects. The aim of this study was to characterize patient preferences for celecoxib and aspirin. Participants completed a computer-based patient decision-making questionnaire that included an educational component outlining the benefits and harms of celecoxib and aspirin. Under the base conditions 7.4% would take celecoxib and 43.6% would take aspirin; males were more willing than females to take aspirin. Patients identified the increased risk of myocardial infarction and gastrointestinal events as the primary reasons for their unwillingness to take celecoxib and aspirin, respectively. A majority of subjects would not take either drug, after considering their benefits and harms, although participants were almost six times more likely to take aspirin than celecoxib. These data serve to inform physicians and researchers regarding the variability and factors that affect patient preferences for CRC chemoprevention.


Related Articles

  • Study: Aspirin as effective as warfarin/aspirin.  // Drug Utilization Review;Mar2002, Vol. 18 Issue 3, p22 

    Discusses the study reported in the February 5, 2002 issue of 'Circulation' about the effectiveness of aspirin monotherapy in the reduction of risk for heart attack. Comparison on the efficacy of warfarin and aspirin combination therapy with the efficacy of aspirin monotherapy; Outcome in...

  • Long-term use of ticagrelor in patients with prior heart attack: ticagrelor plus aspirin versus aspirin monotherapy. Amico, Frank; Schlesinger, Alex; Mazzoni, Jennifer // Postgraduate Medicine;Mar2016, Vol. 128 Issue 2, p164 

    Review of: Bonaca MP, Bhatt DL, Cohen M, et al. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015;372:1791-1800. This Practice Pearl reviews the recent study Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor...

  • Aspirin.  // Reactions Weekly;8/29/2009, Issue 1267, p8 

    The article presents the cases of two men who developed spontaneous perirenal haematomas while receiving aspirin for antiplatelet therapy. The first patient, a 57-year-old man with a history of acute coronary syndrome, reported a constant left flank pain for 6 hours that radiated to his left...

  • Aspirin.  // Reactions Weekly;2/24/2007, Issue 1140, p7 

    The article presents a case report involving a 79-year-old man who developed small bowel enteropathy after undergoing chronic aspirin therapy following a myocardial infarction. It references a study by J. M. Rawlins and M. Riaz published in the January 2007 issue of the "Journal of...

  • The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial. Hideki Ishikawa; Michihiro Mutoh; Sadao Suzuki; Shinkan Tokudome; Yoshihisa Saida; Takashi Abe; Shozo Okamura; Masahiro Tajika; Takashi Joh; Shinji Tanaka; Shin-ei Kudo; Takahisa Matsuda; Masaki Iimuro; Tomomi Yukawa; Tetsuji Takayama; Yasushi Sato; Kyowon Lee; Shinji Kitamura; Motowo Mizuno; Yasushi Sano // Gut;Nov2014, Vol. 63 Issue 11, p1755 

    Objective: To evaluate the influence of low-dose, enteric-coated aspirin tablets (100 mg/day for 2 years) on colorectal tumour recurrence in Asian patients with single/multiple colorectal tumours excised by endoscopy. Design: A double-blinded, randomised, placebocontrolled multicentre clinical...

  • Celecoxib/sulfasalazine.  // Reactions Weekly;9/15/2012, Issue 1419, p15 

    The article describes the case of a 33-year-old woman with rheumatoid arthritis who developed a drug rash with eosinophilia and systemic systems (DRESS) following sulfasalazine and celecoxib therapy.

  • AN ASPIRIN A DAY? Alleyne, Sonia // Black Enterprise;Aug2002, Vol. 33 Issue 1, p112 

    Answers a question on the link between aspirin intake and heart attacks. Advice on aspirin therapy; Concern on the combination of aspirin and pain relievers.

  • Aspirin for the Prevention of Cardiovascular Disease: Recommendation Statement.  // American Family Physician;6/15/2011, Vol. 83 Issue 12, p1464 

    The article discusses the U.S. Preventive Services Task Force's (USPSTF) recommendation on aspirin use to prevent myocardial infarction (MI) in men 45 to 79 years old and ischemic stroke in women 55 to 79 years. According to the USPSTF, there is insufficient evidence to determine the balance of...

  • Aspirin.  // Reactions Weekly;1/5/2013, Issue 1433, p10 

    The article describes the case of a 50-year-old woman who experienced exacerbated respiratory disease while undergoing aspirin therapy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics